FETCROJA 1g powder for concentrate for solution for infusion SHIONOGI B.V.
Active substance: cefiderocol
Indicated for: bacterial infections
Find medicines for human use by name or active substance.
Browse by initial
301–320 of 836 medicines
Active substance: cefiderocol
Indicated for: bacterial infections
Active substance: fluvoxamine
N06AB08 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluvoxamine
N06AB08 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluvoxamine
N06AB08 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluvoxamine
N06AB08 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fexofenadine
Indicated for: allergic rhinitis; urticaria
Active substance: fexofenadine
Indicated for: allergic rhinitis; urticaria
Active substance: trandolapril
C09AA10 Cardiovascular system | Ace inhibitors, plain
Indicated for: hypertension
Active substance: trandolapril
C09AA10 Cardiovascular system | Ace inhibitors, plain
Indicated for: hypertension
Active substance: trandolapril
C09AA10 Cardiovascular system | Ace inhibitors, plain
Indicated for: hypertension
Active substance: trandolapril
C09AA10 Cardiovascular system | Ace inhibitors, plain
Indicated for: hypertension
Active substance: insulin aspart
Indicated for: diabetes mellitus
Active substance: insulin aspart
Indicated for: diabetes mellitus
Active substance: insulin aspart
Indicated for: diabetes mellitus
Active substance: sodium tetradecyl sulfate
C05BB04 Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection
Indicated for: varicose veins; venous sclerotherapy
Active substance: sodium tetradecyl sulfate
C05BB04 Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection
Indicated for: varicose veins; venous sclerotherapy
Active substance: sodium tetradecyl sulfate
C05BB04 Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection
Indicated for: varicose veins; venous sclerotherapy
Active substance: sodium tetradecyl sulfate
C05BB04 Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection
Indicated for: varicose veins; venous sclerotherapy
Active substance: human fibrinogen
B02BB01 Blood and blood forming organs | Vitamin k and other hemostatics | Fibrinogen
Indicated for: bleeding; coagulation disorders
Active substance: human fibrinogen
B02BB01 Blood and blood forming organs | Vitamin k and other hemostatics | Fibrinogen
Indicated for: bleeding; coagulation disorders
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.